| 000 | 01800 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513074551.0 | ||
| 264 | 0 | _c19930309 | |
| 008 | 199303s 0 0 eng d | ||
| 022 | _a0091-3057 | ||
| 024 | 7 |
_a10.1016/0091-3057(93)90279-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDeHaven-Hudkins, D L | |
| 245 | 0 | 0 |
_aOpioid agonist properties of two oxime derivatives of naltrexone, NPC 831 and NPC 836. _h[electronic resource] |
| 260 |
_bPharmacology, biochemistry, and behavior _cJan 1993 |
||
| 300 |
_a45-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _a3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer |
| 650 | 0 | 4 | _aAcetates |
| 650 | 0 | 4 |
_aAnalgesics _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 | _aBombesin |
| 650 | 0 | 4 | _aEnkephalin, Ala(2)-MePhe(4)-Gly(5)- |
| 650 | 0 | 4 |
_aEnkephalin, Leucine-2-Alanine _xmetabolism |
| 650 | 0 | 4 |
_aEnkephalins _xmetabolism |
| 650 | 0 | 4 | _aGuinea Pigs |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNaltrexone _xanalogs & derivatives |
| 650 | 0 | 4 |
_aOximes _xpharmacology |
| 650 | 0 | 4 |
_aPain _xchemically induced |
| 650 | 0 | 4 |
_aPyrrolidines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReaction Time _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Opioid _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Opioid, kappa _xdrug effects |
| 700 | 1 | _aKomer, K M | |
| 700 | 1 | _aPeterson, J A | |
| 700 | 1 | _aMavunkel, B J | |
| 700 | 1 | _aRzeszotarski, W J | |
| 773 | 0 |
_tPharmacology, biochemistry, and behavior _gvol. 44 _gno. 1 _gp. 45-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0091-3057(93)90279-3 _zAvailable from publisher's website |
| 999 |
_c8380820 _d8380820 |
||